Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05044104 · ClinicalTrials.gov registry record · NA

Wearable Technology in Endoscopy

A NA study of Healthy, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
292
Enrollment target
1
Study location

NCT05044104: Completed NA study of Healthy, sponsored by Mayo Clinic.

NCT05044104 is a NA study of Healthy that has completed, run by Mayo Clinic. The registered enrollment target is 292 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05044104, a NA study of Healthy, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
292 participants
Enrollment target
1
Study location

Study Summary

Researchers are assessing the accuracy and safety of wearable technology in subjects undergoing endoscopic gastrointestinal procedures with sedation.

Primary Outcome

Number of tachycardia events recorded as defined as heart rate \> 100 bpm

Conditions Studied

Interventions

  • DEVICE Consumer-facing wearable smart watch

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 292 participants
Start Date 2022-01-11
Est. Completion 2022-09-01
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT05044104 record still lists

NCT05044104 is an interventional study that assigns participants to a tested intervention. The registered 292 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (55% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Consumer-facing wearable smart watch is the first listed.

NCT05044104 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT05044104 about?

NCT05044104 is a clinical study titled "Wearable Technology in Endoscopy". Researchers are assessing the accuracy and safety of wearable technology in subjects undergoing endoscopic gastrointestinal procedures with sedation.

What is the current status of trial NCT05044104?

This trial is currently completed. It is a NA study. The enrollment target is 292 participants. The study started on 2022-01-11. Estimated completion is 2022-09-01.

What conditions does trial NCT05044104 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT05044104?

The interventions under investigation include: Consumer-facing wearable smart watch (DEVICE).

Who is sponsoring clinical trial NCT05044104?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05044104 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05044104's enrollment target sits among peer trials

292 89th of 1090 higher than 1,002 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04429542 · 292 participants · Phase 1

    Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • NCT05406622 · 292 participants · NA

    MOTIV BTK Randomized Controlled Trial

  • NCT05757102 · 292 participants · Phase 3

    A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

  • NCT06569667 · 292 participants · NA

    Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05044104, the US trial registry maintained by the National Library of Medicine. NCT05044104 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.